Triple
T17319877
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Sudan ebolavirus |
E420528
|
entity |
| Predicate | antiviralTherapyStatus |
P122521
|
FINISHED |
| Object | no specific antiviral approved as of 2024 |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: no specific antiviral approved as of 2024 | Statement: [Sudan ebolavirus, antiviralTherapyStatus, no specific antiviral approved as of 2024]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: antiviralTherapyStatus Context triple: [Sudan ebolavirus, antiviralTherapyStatus, no specific antiviral approved as of 2024]
-
A.
hasReceivedTreatmentFor
Indicates that an entity has undergone or been given a treatment in relation to a specified condition, issue, or problem.
-
B.
hasNoApprovedDrugTreatment
chosen
Indicates that there is currently no officially approved drug-based treatment available for the condition or situation in question.
-
C.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
D.
virusSubtype
Indicates the specific subtype classification of a virus within a broader virus type or strain.
-
E.
usesViralVector
Indicates that one entity employs a viral vector as a delivery mechanism or tool to introduce genetic material or components into another entity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d889d22b848190a4663d0b8f8f76e7 |
completed | April 10, 2026, 5:25 a.m. |
| NER | Named-entity recognition | batch_69e439a066b481908e8aee1885809eba |
completed | April 19, 2026, 2:10 a.m. |
| PD | Predicate disambiguation | batch_69e3b01b9d1c8190a406dd941c9b11a1 |
completed | April 18, 2026, 4:23 p.m. |
Created at: April 10, 2026, 5:43 a.m.